BioPorto: Mission and Vision
BioPorto will constantly seek to select new diagnostic biomarker targets from the marketed antibody portfolio that have clinical relevance, potential for a large market in routine diagnostics and for patent protection and by this selection achieve as large a share of the routine diagnostic market as possible.
Share information
Investor Relations
To BioPorto, openness and transparency are essential in maintaining good relations with investors.
The purpose of Investor Relations and this website is to ensure that correct and adequate information about BioPorto is made available to all interested parties simultaneously, regularly and consistently.
Investor news
Newsletter 02
April 23 2008
06: Issue of warrants
April 01 2008
05: Devl. of Annual General Meeting
March 28 2008
Grusbakken 8
DK-2820 Gentofte
Denmark
